Read only on LitRes

The book cannot be downloaded as a file, but can be read in our app or online on the website.

Pharmaceutical Biotechnology
ТекстtextPDF

Volume 500 pages

0+

Pharmaceutical Biotechnology

Concepts and Applications
author
gary walsh
Read only on LitRes

The book cannot be downloaded as a file, but can be read in our app or online on the website.

$289.14

About the book

Pharmaceutical Biotechnology offers students taking Pharmacy and related Medical and Pharmaceutical courses a comprehensive introduction to the fast-moving area of biopharmaceuticals. With a particular focus on the subject taken from a pharmaceutical perspective, initial chapters offer a broad introduction to protein science and recombinant DNA technology- key areas that underpin the whole subject. Subsequent chapters focus upon the development, production and analysis of these substances. Finally the book moves on to explore the science, biotechnology and medical applications of specific biotech products categories. These include not only protein-based substances but also nucleic acid and cell-based products. introduces essential principles underlining modern biotechnology- recombinant DNA technology and protein science an invaluable introduction to this fast-moving subject aimed specifically at pharmacy and medical students includes specific ‘product category chapters’ focusing on the pharmaceutical, medical and therapeutic properties of numerous biopharmaceutical products. entire chapter devoted to the principles of genetic engineering and how these drugs are developed. includes numerous relevant case studies to enhance student understanding no prior knowledge of protein structure is assumed

Leave a review

Log in, to rate the book and leave a review
Book Gary Walsh «Pharmaceutical Biotechnology» — read online on the website. Leave comments and reviews, vote for your favorites.
Age restriction:
0+
Release date on Litres:
20 August 2019
Volume:
500 p.
ISBN:
9780470512234
Total size:
8.9 МБ
Total number of pages:
500
Copyright holder:
John Wiley & Sons Limited